Insulin Detemir in Obesity Management

NAActive, not recruitingINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

April 30, 2011

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
DiabetesObesity
Interventions
DRUG

Detemir

"Subjects randomized to insulin detemir treatment group will receive the basal insulin in a 3 mL. Flex Pen® containing 300 units of insulin. insulin detemir once daily administered with the evening meal (dinner) or at bedtime as add-on to their oral antihyperglycemia (see inclusion/exclusion criteria) meds throughout the 24 week treatment period. The goal of insulin therapy is to achieve near normoglycemia with a low rate of hypoglycaemic episodes.~Insulin injections will be given subcutaneously preferably in the thigh or abdomen."

Trial Locations (1)

37232

Vanderbilt University, Nashville

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Novo Nordisk A/S

INDUSTRY

lead

Vanderbilt University

OTHER